Clinical Trials Browser

Terminated × Interventional × olaratumab × Clear all

NCT03698227 2020-07-15

OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients

Phase 2 Terminated

Sarcoma

NCT01316263 2017-03-09

A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Phase 2 Terminated

21 enrolled 24 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors